Eli Lilly and Co (LLY)
829.76
-39.82
(-4.58%)
USD |
NYSE |
Mar 10, 16:00
822.00
-7.76
(-0.94%)
Pre-Market: 07:17
Eli Lilly Market Cap: 745.27B for March 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen Inc | 175.86B |
| Regeneron Pharmaceuticals Inc | 81.43B |
| Vertex Pharmaceuticals Inc | 128.40B |
| Viking Therapeutics Inc | 3.138B |
| Moderna Inc | 13.87B |
Market Cap Related Metrics
| PE Ratio | 70.86 |
| PS Ratio | 16.65 |
| PEG Ratio | 0.6954 |
| Price to Book Value | 52.51 |
| Price to Free Cash Flow | 1810.55 |
| Price | 829.76 |
| Earnings Yield | 1.41% |
| PEGY Ratio | 0.691 |
| Operating PE Ratio | 42.86 |
| Normalized PE Ratio | 55.60 |